Beta-klotho (Klb) is an auxiliary receptor for the normal physiological functions of FGF15/19 and FGF21, which has been shown to counteract hepatic steatosis by coordinating the control of “stimulating fatty acid oxidation” and “inhibiting fatty acid synthesis” [76,77]. This evidence concerns the gene KLB and fatty liver disease.